Shenzhen Enduring Biotech
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- Undisclosed
Investors
- 5
About Shenzhen Enduring Biotech
Based in Shenzhen, China, and established in 2018, Shenzhen Enduring Biotech LTD. is a drugs developer that focuses on developing innovative bispecific antibody therapeutics and biobetter medicines. The company was established by scientists from pharmaceutical companies and academic institute. The founders of the company come from several different yet complementary scientific disciplines in the drug development industry and who are inventors of numerous patents. The company product lines include double antibody, double antibody drug conjugate (ADC), used the technology of dual-target pegylation, which JY108 of double antibody can be used to treat autoimmune diseases. The company developed patented technology of double site-specific bispecific antibody (DSP-BsAb), which could be used to bispecific antibody therapeutics for cancer immunotherapy as well as for combination therapy with synergistic effect. The company plans to accelerate to apply JY108 bi-antibody investigational new drug (IND), develop early research of new project, build preparation of pilot sites, and expand team.
Who invested in Shenzhen Enduring Biotech
5 investors across 2 rounds
See all investors in Shenzhen Enduring Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shenzhen Enduring Biotech
Who invested in Shenzhen Enduring Biotech?
Shenzhen Enduring Biotech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Enduring Biotech raised?
Shenzhen Enduring Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shenzhen Enduring Biotech last raise money?
Shenzhen Enduring Biotech's most recent round on record is a Series A, in Oct 2021.
What does Shenzhen Enduring Biotech do?
Based in Shenzhen, China, and established in 2018, Shenzhen Enduring Biotech LTD.
Where is Shenzhen Enduring Biotech headquartered?
Shenzhen Enduring Biotech is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Enduring Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shenzhen Enduring Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shenzhen Enduring Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.